NewsWatch: What we still don’t know about COVID vaccines after the U.K.’s emergency-use authorization of the Pfizer-BioNTech candidate

This post was originally published on this site

MARKETWATCH FRONT PAGE

The U.K. government granted emergency use authorization to the COVID-19 vaccine being developed by Pfizer Inc. and German partner BioNTech SE with some fanfare on Wednesday, but experts cautioned that the news does not mean the pandemic is close to being over. See full story.

20 electric vehicle stocks outside of Tesla and Nio expected by analysts to rise the most over the next year

Analysts favor companies that supply EV manufacturers or develop technology to support infrastructure and autonomous driving. See full story.

Post-election political estrangement has landed U.S. at ‘tipping point,’ warns world’s biggest hedge-fund manager

“People and politicians are now at each other’s throats to a degree greater than at any time in my 71 years,” Bridgewater’s Ray Dalio wrote. See full story.

Why the 2020s could favor market-timers over buy-and-hold U.S. stock investors

International stocks, gold and bonds may be a better bet for the next decade. See full story.

Salesforce stock closes down more than 8% as Wall Street questions necessity of Slack purchase

Salesforce.com Inc. shares fall after picking up the rare Wall Street downgrade, and as other analysts wonder if the cloud-based customer-relationship management company is biting off more than it can chew. See full story.

MARKETWATCH PERSONAL FINANCE

‘My sister also does not want to sell the property because it has been in the family for 90 years.’ See full story.